Kavita Natrajan

Oncology
2150 Pennsylvania Ave NW Ste 8-416
Washington, DC 20037

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications

FDA Approval Summary: Ciltacabtagene Autoleucel for Relapsed or Refractory Multiple Myeloma.

FDA Approval Summary: Ciltacabtagene Autoleucel for Relapsed or Refractory Multiple Myeloma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 01, 2024

Bilateral nonpitting edema and xerotic skin.

Bilateral nonpitting edema and xerotic skin.

Journal: The Journal of family practice
Published: April 04, 2018
Showing 1-2 of 2

Last Updated: 09/26/2026